CDMO for microbial cell lines and processes

CDMO service

The pharmaceutical industry is faced with a multitude of challenges throughout the lengthy and complex processes involved in the development and manufacturing of new drug substances. Therefore a partnership with the appropriate contract development and manufacturing organization (CDMO) facilitates the market introduction of pharmaceutical products by providing expertise and reducing costs.

ARTES’ CDMO services:

• microbial cell line and process development
• manufacturing of high quality test and preclinical material
• vaccine development

License Offer

We offer our customers a variety of pre-developed processes for the production of recombinant proteins.
These “ready-to-use” processes for biosimilars, vaccines, enzymes and other products save the customer development time and costs compared to newly manufactured processes. As a result, the target product can be brought to market much more quickly and reliably.

Our customers receive proprietary cell lines and all necessary documentation as part of a technology transfer, together with comprehensive after-sales support.

Licenses are available at fair prices.

ARTES’ license offer:

• ready-to-use processes  for biosimilars, vaccines and enzymes from ARTES’ internal development reducing time-to-market
• technology transfer and licensing of our proprietary cell lines and processes

Lab Reagents

At our Lab Reagents webshop, we offer a selection of recombinant antigens, enzymes and functional proteins for use as research reagents. We are dedicated to streamlining your daily laboratory operations.
Our products are manufactured using our proprietary yeast platform, Hansenula polymorpha, or the bacterium E. coli. We guarantee that our products are manufactured under strict quality controls. This ensures a high level of purity and consistency in our products.

Please visit our webshop. There you will find an overview of our range.

ARTES’ reagents:

• antigens
• enzymes
• functional proteins